Victory Capital Management Inc Aim Immuno Tech Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$1.9 - $2.94 $8,234 - $12,741	-4,334 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$0.56 - $6.1 $1,615 - $17,598	2,885 Added 199.1%	4,334 $11,000
Q4 2019 Feb 04, 2020	BUY	$0.39 - $0.71 $420 - $766	1,079 Added 291.62%	1,449 $1,000
Q3 2019 Nov 12, 2019	BUY	$0.71 - $4.42 $262 - $1,635	370 New	370 $0

9.01M

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $9.61M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.